RCUS

RCUS Operating Cash Flow (Statement)

-$474.00MTTM · USD

Period ending:

RCUS FY Cash from OperationsUSD
RCUS FY Cash from Operations2016-12-31: -$12.94M2017-12-31: -$25.06M2018-12-31: -$43.00M2019-12-31: -$73.46M2020-12-31: $111.17M2021-12-31: -$256.17M2022-12-31: $438.00M2023-12-31: -$306.00M2024-12-31: -$170.00M2025-12-31: -$482.00M$438.00M-$482.00M
2016-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

RCUS operating cash flow (statement) history

Net cash provided by operating activities. The available annual fiscal periods series contains 10 observations from Dec 31, 2016 to Dec 31, 2025.

Arcus Biosciences Inc Operating Cash Flow (Statement) — Annual fiscal periods (USD)
Period endingOperating Cash Flow (Statement) (USD)
-482,000,000
-170,000,000
-306,000,000
438,000,000
-256,171,000
111,170,000
-73,462,000
-42,996,000
-25,059,000
-12,944,000

Compare operating cash flow (statement)

All RCUS financial metrics · RCUS stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.